Advanced-phase chronic myeloid leukemia

Keyphrases

• Chronic Myeloid Leukemia 100%
• Accelerated Phase 100%
• Advanced Phase 100%
• Blastic Phase 80%
• Chronic Phase 60%
• Imatinib 40%
• Cytogenetic Remission 40%
• Effective Treatment 20%
• In Vitro Study 20%
• Interferon-α (IFN-α) 20%
• Farnesyltransferase Inhibitor 20%
• Patient Management 20%
• Previously Untreated Patients 20%
• Survival Benefit 20%
• Outcome Comparison 20%
• Long-term Prognosis 20%
• Imatinib Mesylate 20%
• Cytogenetic Response 20%
• Hematological Response 20%
• Decitabine 20%
• Previously Treated Patients 20%
• Clofarabine 20%
• Troxacitabine 20%
• Homoharringtonine 20%
• Combination Studies 20%

Medicine and Dentistry

• Myeloid Leukemia 100%
• Imatinib 100%
• Diseases 66%
• In Vitro 33%
• Decitabine 33%
• Chronic Myelogenous Leukemia 33%
• Farnesyltransferase Inhibitor 33%
• Interferon Alfa 33%
• Omacetaxine Mepesuccinate 33%
• Clofarabine 33%
• Troxacitabine 33%
• Effective Treatment 33%